Literature DB >> 16563914

Effects of volume and/or pressure overload secondary to congenital heart disease (tetralogy of fallot or pulmonary stenosis) on right ventricular function using cardiovascular magnetic resonance and B-type natriuretic peptide levels.

Thomas Oosterhof1, Igor I Tulevski, Hubert W Vliegen, Anje M Spijkerboer, Barbara J M Mulder.   

Abstract

The aim of this study was to analyze the effect of pressure and/or volume overload on right ventricular (RV) function and brain natriuretic peptide (BNP) levels in patients with surgically corrected congenital heart disease. Forty-two consecutive patients aged 17 to 57 years (median 30) with congenital heart disease (32 with tetralogy of Fallot and 10 with pulmonary stenosis) were examined. The RV systolic pressure was estimated using Doppler echocardiography. Cardiovascular magnetic resonance imaging was used to obtain the RV volumes, ejection fraction (EF) and corrected EF (cEF). Plasma BNP levels were determined by immunoradiometric assay. Patients were categorized as having volume overload when pulmonary regurgitation was > or =10% and pressure overload when the RV systolic pressure was >40 mm Hg. Patients with RV volume overload had a lower RVEF compared with patients with pressure overload (p = 0.02) and lower left ventricular EF (p <0.001). BNP was higher in patients with volume overload than in patients with pressure overload (p = 0.002). BNP correlated with pulmonary regurgitation, RVEF, RV cEF, and left ventricular EF. In linear regression analysis, RV cEF was an independent predictor for BNP, after adjustment for age. Without the parameter of RV cEF in the regression model, pulmonary regurgitation and RVEF were independently associated with BNP level, after adjustment for age. In conclusion, patients with RV volume overload had higher BNP levels and lower RV function than patients with RV pressure overload. BNP levels were independently associated with the degree of RV volume overload and RV function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563914     DOI: 10.1016/j.amjcard.2005.10.047

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  35 in total

1.  The cause of B-type natriuretic peptide elevation and the dose-dependent effect of angiotensin-converting enzyme inhibitor on patients late after tetralogy of Fallot repair.

Authors:  Takuo Furukawa; Tomoaki Murakami; Michihiko Ueno; Atsuhito Takeda; Satoshi Yakuwa; Hirokuni Yamazawa
Journal:  Pediatr Cardiol       Date:  2011-09-30       Impact factor: 1.655

Review 2.  Right ventricular failure: a novel era of targeted therapy.

Authors:  Dipanjan Banerjee; Francois Haddad; Roham T Zamanian; Jayan Nagendran
Journal:  Curr Heart Fail Rep       Date:  2010-12

3.  Tetralogy of Fallot: in good shape?

Authors:  Barbara J M Mulder; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2008-12-16       Impact factor: 2.357

4.  Midgestation fetal pulmonary annulus size is predictive of outcome in tetralogy of fallot.

Authors:  Kevin Friedman; Sowmya Balasubramanian; Wayne Tworetzky
Journal:  Congenit Heart Dis       Date:  2013-07-03       Impact factor: 2.007

Review 5.  The changing epidemiology of congenital heart disease.

Authors:  Teun van der Bom; A Carla Zomer; Aeilko H Zwinderman; Folkert J Meijboom; Berto J Bouma; Barbara J M Mulder
Journal:  Nat Rev Cardiol       Date:  2010-11-02       Impact factor: 32.419

6.  Right Ventricular Mass is Associated with Exercise Capacity in Adults with Repaired Tetralogy of Fallot.

Authors:  Shamus O'Meagher; Martin Seneviratne; Michael R Skilton; Phillip A Munoz; Peter J Robinson; Nathan Malitz; David J Tanous; David S Celermajer; Rajesh Puranik
Journal:  Pediatr Cardiol       Date:  2015-03-21       Impact factor: 1.655

Review 7.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

8.  QRS Duration During Follow-Up of Tetralogy of Fallot: How Valuable is it? Analysis of ECG Changes in Relation to Pulmonary Valve Implantation.

Authors:  Thomas Martens; Katrien François; Hans De Wilde; Laurence Campens; Laurent Demulier; Julie De Backer; Daniel Dewolf; Thierry Bove
Journal:  Pediatr Cardiol       Date:  2021-05-07       Impact factor: 1.655

9.  Factors associated with serum B-type natriuretic peptide in infants with single ventricles.

Authors:  Ryan J Butts; Victor Zak; Daphne Hsu; James Cnota; Steven D Colan; David Hehir; Paul Kantor; Jami C Levine; Renee Margossian; Marc Richmond; Anita Szwast; Derek Williams; Richard Williams; Andrew M Atz
Journal:  Pediatr Cardiol       Date:  2014-02-13       Impact factor: 1.655

Review 10.  Current Role of Blood and Urine Biomarkers in the Clinical Care of Adults with Congenital Heart Disease.

Authors:  Saurabh Rajpal; Laith Alshawabkeh; Alexander R Opotowsky
Journal:  Curr Cardiol Rep       Date:  2017-06       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.